Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 350
Single User License Price INR 24917
Corporate User License Price USD 1050
Corporate User License Price INR 74750
Site License Price USD 700
Site License Price INR 49833
Request a Quote

Report Title

Pharmaceuticals in Mexico

Quote Request for License Type
License Type Price  
Single User License USD 350
Site License USD 700
Enterprise Wide License USD 1050
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Pharmaceuticals in Mexico


Quote Request for License Type
License Type Price  
Single User License USD 350
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Pharmaceuticals in Mexico

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Pharmaceuticals in Mexico



Executive Summary

Pharmaceuticals in Mexico

Summary

Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Mexico pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The Mexican pharmaceuticals market had total revenues of USD 20.3bn in 2017, representing a compound annual growth rate (CAGR) of 5.8% between 2013 and 2017.

- In line with many developing nations, Mexico has been experiencing an epidemiological transition from communicable diseases to chronic degenerative diseases. It is these factors which are generating growth.

- A growing middle class and better access to health care services are greatly increasing consumer demand for pharmaceutical products in Mexico.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Mexico

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Mexico

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Mexico pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the Mexico pharmaceuticals market by value in 2017?

- What will be the size of the Mexico pharmaceuticals market in 2022?

- What factors are affecting the strength of competition in the Mexico pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitiors in Mexico's pharmaceuticals market?

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Geography segmentation 10

Market share 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 15

Supplier power 17

New entrants 19

Threat of substitutes 21

Degree of rivalry 22

Leading Companies 24

Bayer AG 24

Merck & Co., Inc. 28

Novartis AG 31

Pfizer Inc. 34

Macroeconomic Indicators 38

Country data 38

Methodology 40

Industry associations 41

Related MarketLine research 41

Appendix 42

About MarketLine 42

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Figure 1: Mexico pharmaceuticals market value: USD billion, 2013-17

Figure 2: Mexico pharmaceuticals market geography segmentation: % share, by value, 2017

Figure 3: Mexico pharmaceuticals market share: % share, by value, 2017

Figure 4: Mexico pharmaceuticals market value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the pharmaceuticals market in Mexico, 2017

Figure 6: Drivers of buyer power in the pharmaceuticals market in Mexico, 2017

Figure 7: Drivers of supplier power in the pharmaceuticals market in Mexico, 2017

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2017

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2017

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2017

Figure 11: Bayer AG: revenues & profitability

Figure 12: Bayer AG: assets & liabilities

Figure 13: Merck & Co., Inc.: revenues & profitability

Figure 14: Merck & Co., Inc.: assets & liabilities

Figure 15: Novartis AG: revenues & profitability

Figure 16: Novartis AG: assets & liabilities

Figure 17: Pfizer Inc.: revenues & profitability

Figure 18: Pfizer Inc.: assets & liabilities

List of Tables

Table 1: Mexico pharmaceuticals market value: USD billion, 2013-17

Table 2: Mexico pharmaceuticals market geography segmentation: USD billion, 2017

Table 3: Mexico pharmaceuticals market share: % share, by value, 2017

Table 4: Mexico pharmaceuticals market value forecast: USD billion, 2017-22

Table 5: Bayer AG: key facts

Table 6: Bayer AG: key financials (USD )

Table 7: Bayer AG: key financials (EUR)

Table 8: Bayer AG: key financial ratios

Table 9: Merck & Co., Inc.: key facts

Table 10: Merck & Co., Inc.: key financials (USD )

Table 11: Merck & Co., Inc.: key financial ratios

Table 12: Novartis AG: key facts

Table 13: Novartis AG: key financials (USD )

Table 14: Novartis AG: key financial ratios

Table 15: Pfizer Inc.: key facts

Table 16: Pfizer Inc.: key financials (USD )

Table 17: Pfizer Inc.: key financial ratios

Table 18: Mexico size of population (million), 2013-17

Table 19: Mexico gdp (constant 2005 prices, USD billion), 2013-17

Table 20: Mexico gdp (current prices, USD billion), 2013-17

Table 21: Mexico inflation, 2013-17

Table 22: Mexico consumer price index (absolute), 2013-17

Table 23: Mexico exchange rate, 2013-17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person